维生素D与心房颤动发病机制的研究进展

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
张家豪,林蓉香,张嘉璇
文章摘要
维生素D是机体不可或缺的维生素,在各个生理过程中都起着重要作用,参与调节体内钙磷代谢的同时,还可影响人体自身免疫、凝血、组织炎症和细胞活性。它分布广泛,在人类有核细胞中普遍表达,其水平受着年龄、性别、光照、激素等多种因素的影响。心房颤动(AF),心律失常中最常见的类型之一,其所带来的主要危害之一是血栓形成脱落导致的卒中风险,各种研究表示促进房颤产生的机制很多,但是到目前为止房颤的形成机制仍不明确,近年研究发现,维生素D与心力衰竭、高血压、冠心病、心肌病、心律失常等多种心血管疾病的发生、发展密切相关。本文主要就维生素D及其水平在房颤发病机制中的作用的最新研究进展做一综述。
文章关键词
维生素D;房颤;RAAS;炎症因子;肥胖
参考文献
[1] Schnabel,R.B.,et al.,Searching for Atrial Fibrillation Poststroke:A White Paper of the AF-SCREEN International Collaboration. Circulation,2019.140(22):p.1834-1850. [2] Chung,M.K.,et al.,Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation:A Scientific Statement From the American Heart Association.Circulation,2020.141(16):p.e750-e772. [3] Elliott,A.D.,et al.,Epidemiology and modifiable risk factors for atrial fibrillation.Nat Rev Cardiol,2023.20(6):p.404-417. [4] 牛思泉and赵育洁,维生素D缺乏与非瓣膜性心房颤动的相关性%J宁夏医科大学学报.2021.43(08):p.836-840. [5] Taşolar,H.,et al.,Is the level of resistin appropriate for predicting atrial fibrillation?J Cardiol,2014.64(5):p.419. [6] Norman,P.E.and J.T.Powell,Vitamin D and cardiovascular disease.Circ Res,2014.114(2):p.379-93. [7] 郭蕊and叶伟,维生素D在心血管疾病中的作用及研究进展%J心血管康复医学杂志.2023.32(02):p.176-179. [8] Saponaro,F.,A.Saba,and R.Zucchi,An Update on Vitamin D Metabolism.Int J Mol Sci,2020.21(18). [9] Christakos,S.,et al.,Vitamin D:metabolism.Endocrinol Metab Clin North Am,2010.39(2):p.243-53,table of contents. [10] Mogire,R.M.,et al.,Prevalence of vitamin D deficiency in Africa:a systematic review and meta-analysis.Lancet Glob Health,2020. 8(1):p.e134-e142. [11] Siddiqee,M.H.,et al.,High prevalence of vitamin D deficiency among the South Asian adults:a systematic review and meta- analysis.BMC Public Health,2021.21(1):p.1823. [12] Duarte,C.,et al.,Prevalence of vitamin D deficiency and its predictors in the Portuguese population:a nationwide population-based study.Arch Osteoporos,2020.15(1):p.36. [13] Cashman,K.D.,Vitamin D Deficiency:Defining,Prevalence,Causes,and Strategies of Addressing.Calcif Tissue Int,2020.106(1):p.14-29. [14] Acharya,P.,et al.,Effects of Vitamin D Supplementation and 25-Hydroxyvitamin D Levels on the Risk of Atrial Fibrillation.Am J Cardiol,2022.173:p.56-63. [15] Chen,W.R.,et al.,Relation of low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients.Ann Noninvasive Electrocardiol,2014.19(2):p.166-73. [16] Belen,E.,et al.,Low-Level Vitamin D Is Associated with Atrial Fibrillation in Patients with Chronic Heart Failure.Adv Clin Exp Med,2016.25(1):p.51-7. [17] Albert,C.M.,et al.,Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation:A Randomized Clinical Trial.Jama,2021.325(11):p.1061-1073. [18] Everett,T.H.t.and J.E.Olgin,Atrial fibrosis and the mechanisms of atrial fibrillation.Heart Rhythm,2007.4(3 Suppl):p.S24-7. [19] Motiwala,S.R.and T.J.Wang,Vitamin D and cardiovascular risk.Curr Hypertens Rep,2012.14(3):p.209-18. [20] Hu,Y.F.,et al.,Inflammation and the pathogenesis of atrial fibrillation.Nat Rev Cardiol,2015.12(4):p.230-43. [21] Canning,M.O.,et al.,1-alpha,25-Dihydroxyvitamin D3(1,25(OH)(2)D(3))hampers the maturation of fully active immature dendritic cells from monocytes.Eur J Endocrinol,2001.145(3):p.351-7. [22] Li,Q.,et al.,Association of C-reactive protein and vitamin D deficiency with cardiovascular disease:A nationwide cross-sectional study from National Health and Nutrition Examination Survey 2007 to 2008.Clin Cardiol,2019.42(7):p.663-669. [23] Alpert,M.A.,J.Omran,and B.P.Bostick,Effects of Obesity on Cardiovascular Hemodynamics,Cardiac Morphology,and Ventricular Function.Curr Obes Rep,2016.5(4):p.424-434. [24] Haemers,P.,et al.,Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria.Eur Heart J,2017.38(1):p.53-61. [25] Mahajan,R.,et al.,Electrophysiological,Electroanatomical,and Structural Remodeling of the Atria as Consequences of Sustained Obesity.J Am Coll Cardiol,2015.66(1):p.1-11. [26] Golaszewska,K.,et al.,Serum fatty acid binding proteins as a potential biomarker in atrial fibrillation.J Physiol Pharmacol,2019.70(1). [27] Iacobellis,G.and A.C.Bianco,Epicardial adipose tissue:emerging physiological,pathophysiological and clinical features.Trends Endocrinol Metab,2011.22(11):p.450-7. [28] Venteclef,N.,et al.,Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo- fibrokines.Eur Heart J,2015.36(13):p.795-805a. [29] Tedrow,U.B.,et al.,The long-and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS(women's health study).J Am Coll Cardiol,2010.55(21):p.2319-27. [30] Bhattarai,H.K.,et al.,Vitamin D,Calcium,Parathyroid Hormone,and Sex Steroids in Bone Health and Effects of Aging.J Osteoporos, 2020.2020:p.9324505. [31] Özsin,K.K.,et al.,Effect of Plasma Level of Vitamin D on Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting.Braz J Cardiovasc Surg,2018.33(3):p.217-223. [32] Ding,F.,et al.,Data mining:Biological and temporal factors associated with blood parathyroid hormone,vitamin D,and calcium concentrations in the Southwestern Chinese population.Clin Biochem,2021.90:p.50-57.
Full Text:
DOI